Photodynamic Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Photodynamic Therapy Market is Segmented by Product (Photosensitizer Drugs, Photodynamic Therapy Devices), by Applications (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), by End-User (Hospitals, Cancer Treatment Centers, Cosmetic and Dermatology Clinics and Others) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

Photodynamic Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Photodynamic Therapy Market Size

Photodynamic Therapy Market Size
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Photodynamic Therapy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Photodynamic Therapy Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Photodynamic Therapy Market Analysis

The Global Photodynamic Therapy Market is expected to register a CAGR of 7.5% during the forecast period.

Cancer cells have been treated using photodynamic therapy, which also inactivates viruses and other infections. The photodynamic therapy (PDT) method has recently grown in popularity. Photodynamic therapy (PDT) as an alternative or complementary treatment for COVID-19 has been introduced as part of the search for alternative therapeutic techniques for the efficient management of COVID-19. For instance, as per an article titled 'Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation' published in March 2022, to render SARS-CoV-2 inactive, photodynamic disinfection (PDI) was proposed, along with its therapeutic application to COVID-19 patients. It has been emphasized that PDI is a good candidate for treating COVID-19 because SARS-CoV-2 is an enveloped RNA virus, and these viruses are most sensitive to PDI.

The rise in prevalence of cancer and skin disorders, the demand for minimally invasive procedures, and the rising financial burden of cancer are anticipated to drive the expansion of the global market for photodynamic therapy. The market is being driven by increased consumer knowledge of the advantages of photodynamic therapy and an increase in the use of treatments for acne, eyes, and the face. Furtermore, growing R&D in photodynamic treatment analysis is opening attractive commercial potential. The increase in demand for photosensitizer drugs and equipment used in the treatment of different types of cancer is anticipated to propel the growth of the photodynamic therapy market. According to World Health Organization (WHO), Key facts updated in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Thus, the increasing prevalence of cancer cases across the globe is expected to rise the demand for photosensitizer drugs, thereby accelerating the market. As per an article titled 'Actinic Keratosis Risk Factors' published by Skin Cancer Foundation in January 2022, actinic keratosis (AK) is a skin precancer and has a presence across the globe and much in regions near the equator. Actinic keratosis is most frequently brought on by prolonged, unprotected exposure to UV light. The increasing prevalence of actinic keratosis is expected to boost the demand for photodynamic therapy for the treatment & care of actinic keratosis.

However, the high cost of photodynamic therapy and the risk and side effects associated with the therapy is expected to restrain the growth of the market during the forecast period.

Photodynamic Therapy Industry Overview

The Photodynamic Therapy Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are BIOFRONTERA AG, Lumibird (Quantel Medical), Galderma S.A., Bausch Health Companies Inc., and Sun Pharmaceutical Industries Limited. among others.

Photodynamic Therapy Market Leaders

  1. BIOFRONTERA AG

  2. Lumibird (Quantel Medical)

  3. Sun Pharmaceutical Industries Limited

  4. Galderma S.A.

  5. Bausch Health Companies Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Photodynamic Therapy Market_CL.png
Need More Details on Market Players and Competiters?
Download PDF

Photodynamic Therapy Market News

  • In August 2022, Asieris Pharmaceuticals announced its multinational Phase III Clinical Trial of Cevira(APRICITY), novel non-surgical treatment of cervical high-grade squamous intraepithelial lesions (HSIL), has completed enrollment. Cevira is a breakthrough photodynamic drug-device combination product, based on the accumulation of a photosensitizer in the target cells
  • In March 2022, Biofrontera Inc. announced that the previously granted United States patent No. 11,235,169 for the BF-RhodoLED XL illumination device is now listed in the United States Food and Drug Administration (FDA) publication 'Approved Drug Products with Therapeutic Equivalence Evaluations,' commonly known as the Orange Book.

Photodynamic Therapy Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Cancer Around the World
    • 4.2.2 Advancements in Device Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Photodynamic Therapy
    • 4.3.2 Risk and Side Effects Associated With The Therapy
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Photosensitizer Drugs
    • 5.1.1.1 Aminolevulinic Acid
    • 5.1.1.2 Porphyrin Derivatives
    • 5.1.1.3 Chlorines
    • 5.1.1.4 Others
    • 5.1.2 Photodynamic Therapy Devices
    • 5.1.2.1 Diode Lasers
    • 5.1.2.2 Disposable Fiber Optic Light Delivery Devices
  • 5.2 By Applications
    • 5.2.1 Cancer
    • 5.2.2 Actinic Keratosis
    • 5.2.3 Acne
    • 5.2.4 Psoriasis
    • 5.2.5 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Cosmetic and Dermatology Clinics
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biofrontera AG
    • 6.1.2 Lumibird (Quantel Medical)
    • 6.1.3 Galderma S.A.
    • 6.1.4 Bausch Health Companies Inc.
    • 6.1.5 Sun Pharmaceutical Industries Limited
    • 6.1.6 Soligenix
    • 6.1.7 biolitec AG
    • 6.1.8 Modulight, Inc.
    • 6.1.9 Theralase Technologies Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Photodynamic Therapy Industry Segmentation

As per the scope of the report, photodynamic therapy refers to the destruction of abnormal cells using photosensitive medicine along with a light source. It is used in a variety of cancerous and pancreatic conditions. For skin cancers, the drug is placed on the skin or near the skin. For other types of cancers, the drug is given through IV infusion. The Photodynamic Therapy Market is Segmented by Product (Photosensitizer Drugs, Photodynamic Therapy Devices), by Applications (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), by End-User (Hospitals, Cancer Treatment Centers, Cosmetic and Dermatology Clinics and Others) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Photosensitizer Drugs Aminolevulinic Acid
Porphyrin Derivatives
Chlorines
Others
Photodynamic Therapy Devices Diode Lasers
Disposable Fiber Optic Light Delivery Devices
By Applications Cancer
Actinic Keratosis
Acne
Psoriasis
Others
By End-User Hospitals
Cosmetic and Dermatology Clinics
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Photodynamic Therapy Market Research FAQs

What is the current Global Photodynamic Therapy Market size?

The Global Photodynamic Therapy Market is projected to register a CAGR of 7.5% during the forecast period (2025-2030)

Who are the key players in Global Photodynamic Therapy Market?

BIOFRONTERA AG, Lumibird (Quantel Medical), Sun Pharmaceutical Industries Limited, Galderma S.A. and Bausch Health Companies Inc. are the major companies operating in the Global Photodynamic Therapy Market.

Which is the fastest growing region in Global Photodynamic Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Photodynamic Therapy Market?

In 2025, the North America accounts for the largest market share in Global Photodynamic Therapy Market.

What years does this Global Photodynamic Therapy Market cover?

The report covers the Global Photodynamic Therapy Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Photodynamic Therapy Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Photodynamic Therapy Industry Report

Statistics for the 2025 Global Photodynamic Therapy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Photodynamic Therapy analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.